United States Gastrointestinal Cancer Drug Market Report 2017

September 2017 | 95 pages | ID: UBF2BC312B7EN
QYResearch

Abstracts

In this report, the United States Gastrointestinal Cancer Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Gastrointestinal Cancer Drug in these regions, from 2012 to 2022 (forecast).

United States Gastrointestinal Cancer Drug market competition by top manufacturers/players, with Gastrointestinal Cancer Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Celgene Corporation
• F. Hoffmann-La Roche Ltd.
• Eli Lilly and Company
• GlaxoSmithKline plc.
• Pfizer Inc.
• Sanofi
• Novartis AG.
• Bristol-Myers Squibb Company
• Amgen Limited & Amgen Ireland Limited
• Johnson & Johnson Private Limited

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• By Therapy
• Immunotherapy
• Chemotherapy
• Targeted Therapy
• Radiation Therapy
• Hormone Therapy
• Adjuvant Chemotherapy
• By Route of Administration
• Oral
• Injectable Therapy

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Gastrointestinal Cancer Drug for each application, including

• Radiology
• Oncology

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Gastrointestinal Cancer Drug Market Report 2017

1 GASTROINTESTINAL CANCER DRUG OVERVIEW

1.1 Product Overview and Scope of Gastrointestinal Cancer Drug
1.2 Classification of Gastrointestinal Cancer Drug by Product Category
  1.2.1 United States Gastrointestinal Cancer Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Gastrointestinal Cancer Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Immunotherapy
  1.2.4 Chemotherapy
  1.2.5 Targeted Therapy
  1.2.6 Radiation Therapy
  1.2.7 Hormone Therapy
  1.2.8 Adjuvant Chemotherapy
1.3 United States Gastrointestinal Cancer Drug Market by Application/End Users
  1.3.1 United States Gastrointestinal Cancer Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Radiology
  1.3.3 Oncology
1.4 United States Gastrointestinal Cancer Drug Market by Region
  1.4.1 United States Gastrointestinal Cancer Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
  1.4.5 New England Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
  1.4.6 The South Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Gastrointestinal Cancer Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Gastrointestinal Cancer Drug (2012-2022)
  1.5.1 United States Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Gastrointestinal Cancer Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES GASTROINTESTINAL CANCER DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Gastrointestinal Cancer Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Gastrointestinal Cancer Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Gastrointestinal Cancer Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Gastrointestinal Cancer Drug Market Competitive Situation and Trends
  2.4.1 United States Gastrointestinal Cancer Drug Market Concentration Rate
  2.4.2 United States Gastrointestinal Cancer Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Gastrointestinal Cancer Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES GASTROINTESTINAL CANCER DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Gastrointestinal Cancer Drug Sales and Market Share by Region (2012-2017)
3.2 United States Gastrointestinal Cancer Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Gastrointestinal Cancer Drug Price by Region (2012-2017)

4 UNITED STATES GASTROINTESTINAL CANCER DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Gastrointestinal Cancer Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Gastrointestinal Cancer Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Gastrointestinal Cancer Drug Price by Type (2012-2017)
4.4 United States Gastrointestinal Cancer Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES GASTROINTESTINAL CANCER DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Gastrointestinal Cancer Drug Sales and Market Share by Application (2012-2017)
5.2 United States Gastrointestinal Cancer Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES GASTROINTESTINAL CANCER DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Celgene Corporation
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Celgene Corporation Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 F. Hoffmann-La Roche Ltd.
  6.2.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Eli Lilly and Company
  6.3.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Eli Lilly and Company Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline plc.
  6.4.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Pfizer Inc.
  6.5.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Pfizer Inc. Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Sanofi
  6.6.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sanofi Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Novartis AG.
  6.7.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Novartis AG. Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bristol-Myers Squibb Company
  6.8.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Amgen Limited & Amgen Ireland Limited
  6.9.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Johnson & Johnson Private Limited
  6.10.2 Gastrointestinal Cancer Drug Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 GASTROINTESTINAL CANCER DRUG MANUFACTURING COST ANALYSIS

7.1 Gastrointestinal Cancer Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Gastrointestinal Cancer Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Gastrointestinal Cancer Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Gastrointestinal Cancer Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES GASTROINTESTINAL CANCER DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Gastrointestinal Cancer Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Gastrointestinal Cancer Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Gastrointestinal Cancer Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Gastrointestinal Cancer Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Gastrointestinal Cancer Drug
Figure United States Gastrointestinal Cancer Drug Market Size (MT) by Type (2012-2022)
Figure United States Gastrointestinal Cancer Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Immunotherapy Product Picture
Figure Chemotherapy Product Picture
Figure Targeted Therapy Product Picture
Figure Radiation Therapy Product Picture
Figure Hormone Therapy Product Picture
Figure Adjuvant Chemotherapy Product Picture
Figure United States Gastrointestinal Cancer Drug Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Gastrointestinal Cancer Drug by Application in 2016
Figure Radiology Examples
Table Key Downstream Customer in Radiology
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure United States Gastrointestinal Cancer Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2022)
Figure United States Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Gastrointestinal Cancer Drug Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Gastrointestinal Cancer Drug Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Gastrointestinal Cancer Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Gastrointestinal Cancer Drug Sales Share by Players/Suppliers
Figure 2017 United States Gastrointestinal Cancer Drug Sales Share by Players/Suppliers
Figure United States Gastrointestinal Cancer Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Gastrointestinal Cancer Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Gastrointestinal Cancer Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Gastrointestinal Cancer Drug Revenue Share by Players/Suppliers
Figure 2017 United States Gastrointestinal Cancer Drug Revenue Share by Players/Suppliers
Table United States Market Gastrointestinal Cancer Drug Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Gastrointestinal Cancer Drug Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States Gastrointestinal Cancer Drug Market Share of Top 3 Players/Suppliers
Figure United States Gastrointestinal Cancer Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Gastrointestinal Cancer Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Gastrointestinal Cancer Drug Product Category
Table United States Gastrointestinal Cancer Drug Sales (MT) by Region (2012-2017)
Table United States Gastrointestinal Cancer Drug Sales Share by Region (2012-2017)
Figure United States Gastrointestinal Cancer Drug Sales Share by Region (2012-2017)
Figure United States Gastrointestinal Cancer Drug Sales Market Share by Region in 2016
Table United States Gastrointestinal Cancer Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Gastrointestinal Cancer Drug Revenue Share by Region (2012-2017)
Figure United States Gastrointestinal Cancer Drug Revenue Market Share by Region (2012-2017)
Figure United States Gastrointestinal Cancer Drug Revenue Market Share by Region in 2016
Table United States Gastrointestinal Cancer Drug Price (USD/Kg) by Region (2012-2017)
Table United States Gastrointestinal Cancer Drug Sales (MT) by Type (2012-2017)
Table United States Gastrointestinal Cancer Drug Sales Share by Type (2012-2017)
Figure United States Gastrointestinal Cancer Drug Sales Share by Type (2012-2017)
Figure United States Gastrointestinal Cancer Drug Sales Market Share by Type in 2016
Table United States Gastrointestinal Cancer Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Gastrointestinal Cancer Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Gastrointestinal Cancer Drug by Type (2012-2017)
Figure Revenue Market Share of Gastrointestinal Cancer Drug by Type in 2016
Table United States Gastrointestinal Cancer Drug Price (USD/Kg) by Types (2012-2017)
Figure United States Gastrointestinal Cancer Drug Sales Growth Rate by Type (2012-2017)
Table United States Gastrointestinal Cancer Drug Sales (MT) by Application (2012-2017)
Table United States Gastrointestinal Cancer Drug Sales Market Share by Application (2012-2017)
Figure United States Gastrointestinal Cancer Drug Sales Market Share by Application (2012-2017)
Figure United States Gastrointestinal Cancer Drug Sales Market Share by Application in 2016
Table United States Gastrointestinal Cancer Drug Sales Growth Rate by Application (2012-2017)
Figure United States Gastrointestinal Cancer Drug Sales Growth Rate by Application (2012-2017)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Celgene Corporation Gastrointestinal Cancer Drug Sales Growth Rate (2012-2017)
Figure Celgene Corporation Gastrointestinal Cancer Drug Sales Market Share in United States (2012-2017)
Figure Celgene Corporation Gastrointestinal Cancer Drug Revenue Market Share in United States (2012-2017)
Table F. Hoffmann-La Roche Ltd. Basic Information List
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales Market Share in United States (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Revenue Market Share in United States (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Gastrointestinal Cancer Drug Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company Gastrointestinal Cancer Drug Sales Market Share in United States (2012-2017)
Figure Eli Lilly and Company Gastrointestinal Cancer Drug Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline plc. Basic Information List
Table GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline plc. Gastrointestinal Cancer Drug Revenue Market Share in United States (2012-2017)
Table Pfizer Inc. Basic Information List
Table Pfizer Inc. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer Inc. Gastrointestinal Cancer Drug Sales Growth Rate (2012-2017)
Figure Pfizer Inc. Gastrointestinal Cancer Drug Sales Market Share in United States (2012-2017)
Figure Pfizer Inc. Gastrointestinal Cancer Drug Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi Gastrointestinal Cancer Drug Sales Growth Rate (2012-2017)
Figure Sanofi Gastrointestinal Cancer Drug Sales Market Share in United States (2012-2017)
Figure Sanofi Gastrointestinal Cancer Drug Revenue Market Share in United States (2012-2017)
Table Novartis AG. Basic Information List
Table Novartis AG. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis AG. Gastrointestinal Cancer Drug Sales Growth Rate (2012-2017)
Figure Novartis AG. Gastrointestinal Cancer Drug Sales Market Share in United States (2012-2017)
Figure Novartis AG. Gastrointestinal Cancer Drug Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Revenue Market Share in United States (2012-2017)
Table Amgen Limited & Amgen Ireland Limited Basic Information List
Table Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales Growth Rate (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales Market Share in United States (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Private Limited Basic Information List
Table Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastrointestinal Cancer Drug
Figure Manufacturing Process Analysis of Gastrointestinal Cancer Drug
Figure Gastrointestinal Cancer Drug Industrial Chain Analysis
Table Raw Materials Sources of Gastrointestinal Cancer Drug Major Players/Suppliers in 2016
Table Major Buyers of Gastrointestinal Cancer Drug
Table Distributors/Traders List
Figure United States Gastrointestinal Cancer Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Gastrointestinal Cancer Drug Price (USD/Kg) Trend Forecast (2017-2022)
Table United States Gastrointestinal Cancer Drug Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Gastrointestinal Cancer Drug Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Gastrointestinal Cancer Drug Sales Volume (MT) Forecast by Type in 2022
Table United States Gastrointestinal Cancer Drug Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Gastrointestinal Cancer Drug Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Gastrointestinal Cancer Drug Sales Volume (MT) Forecast by Application in 2022
Table United States Gastrointestinal Cancer Drug Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Gastrointestinal Cancer Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Gastrointestinal Cancer Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Gastrointestinal Cancer Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources